PHARMA BIEN-ÊTRE
0776.600.905 · rovalta.com · 25/09/2026
PHARMA BIEN-ÊTRE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMA BIEN-ÊTRE is a Public limited company incorporated in 2021. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Namur. It employs on average 3,1 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0776.600.905
- Incorporation
- 28/10/2021
- Legal form
- Public limited company
- Registered office
- Rue de Sedent(JB) 205 box 21
5100 Namur · WallonieSee on map - Contributed capital
- 200 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 3,1 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 565,9 k € | +160% | 217,9 k € | +6.1% | 205,4 k € | -2.1% | 209,8 k € |
| EBITDA | 261,2 k € | +22.0% | 214 k € | +5.4% | 203,1 k € | -3.2% | 209,8 k € |
| Operating result | 245,8 k € | +22.4% | 200,8 k € | -1.1% | 203,1 k € | -2.2% | 207,8 k € |
| Net result | 397,1 k € | +64.6% | 241,2 k € | +23.0% | 196,1 k € | +47.8% | 132,7 k € |
| Balance sheet | |||||||
| Equity | 1,2 M € | +51.6% | 770,1 k € | +45.6% | 528,9 k € | +58.9% | 332,7 k € |
| Total assets | 4,9 M € | +15.7% | 4,2 M € | +23.4% | 3,4 M € | +2.5% | 3,3 M € |
| Cash | 194 k € | +329% | 45,3 k € | -34.0% | 68,6 k € | -12.6% | 78,5 k € |
| Debts | 3,7 M € | +7.7% | 3,4 M € | +19.3% | 2,9 M € | -3.7% | 3 M € |
| Other | |||||||
| Workforce | 3,1 ETP | – | – | – | |||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Rue de Sedent(JB) 205 5100 Namur| Company | CBE no. |
|---|---|
| 1012.309.519 | |
FONTANOVA● Active | 1017.868.213 |
Groupe Tilman● Active | 1020.730.307 |
LES ATELIERS DU MIEUX VIVRE● Active | 0480.190.976 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 28/10/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 15 months |
| Filing date | 30/06/2026 | 18/07/2025 | 27/06/2024 | 29/06/2023 |
| General meeting | 25/06/2026 | 30/06/2025 | 25/06/2024 | 26/06/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025397,1 k €↑
- 2024Annual accounts 2024241,2 k €↑
- 2023Annual accounts 2023196,1 k €↑
- 2022Annual accounts 2022132,7 k €
- 28/10/2021IncorporationPublic limited company